Skip to main content
. Author manuscript; available in PMC: 2020 Apr 15.
Published in final edited form as: Clin Cancer Res. 2019 Jul 29;25(20):6044–6051. doi: 10.1158/1078-0432.CCR-19-0798

Figure 1.

Figure 1.

Treatment course schema. GM-CSF (250 mg/m2 subcutaneously) was given on days 1 through 2 and days 8 through 14. Hu14.18-IL2 (12 mg/m2/dose) was given as a four-hour intravenous infusion on days 4 through 6. Isotretinoin (160 mg/m2/day, divided twice daily) was given for 14 days starting on day 11.

*Hold GM-CSF 24 hours prior and 24 hours after hu14.18-IL2

**Stop on day 24